TriSalus Life Sciences, Inc. SEC filings TLSIW

TriSalus Life Sciences, Inc. has 493 filings in SEC EDGAR's recent list, going back to Oct 29, 2020. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (other events). The company's fiscal year ends on December 31.

TriSalus Life Sciences, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
10-K Annual report Mar 5, 2026 Dec 31, 2025
10-K/A Amended annual report May 30, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Apr 15, 2025 Dec 31, 2024
ARS Annual report to shareholders Jul 19, 2024 Jun 18, 2024
10-K Annual report Apr 11, 2024 Dec 31, 2023
10-K Annual report Mar 22, 2023 Dec 31, 2022
10-K Annual report Mar 3, 2022 Dec 31, 2021
10-K/A Amended annual report Dec 13, 2021 Dec 31, 2020
10-K/A Amended annual report Jun 28, 2021 Dec 31, 2020
10-K Annual report Mar 31, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TLSI (Nasdaq), TLSIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826667
Former names
MedTech Acquisition Corp (until Aug 10, 2023); MedTech Acquisition Corporation (until Oct 29, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.